NCT00160277View on ClinicalTrials.gov

Efficacy and Safety of Moxonidine in Indian Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

July 31, 2005

Conditions

Hypertension

Interventions

DRUG

Moxonidine

Trial Locations (3)

Unknown

Site 1, Jubillee Hills Hyderabad

Site 2, Mangalore

Site 3, New Delhi

All Listed Sponsors

lead

Solvay Pharmaceuticals

INDUSTRY

NCT00160277 - Efficacy and Safety of Moxonidine in Indian Patients | Biotech Hunter | Biotech Hunter